Do you have the same question? Follow this Question
Nov 06, 2025 - 12:26 PM
We’ve provided several answers to questions related to Follistim AQ , see some other helpful Q&A related to this product.
Question: What is the brand name of this medication?
Answer: The brand name is Follistim AQ. Brand recognition can help patients and providers identify the product and ensure they are using the correct medication.
Question: Are there any known significant drug interactions with this medication?
Answer: There are no known significant interactions. This can offer peace of mind to patients who may be taking other medications.
Question: What is the usual dosing frequency for women?
Answer: For women, it is typically injected subcutaneously once daily, with a slowly increasing dose based on the ovarian response. Individualized dosing helps maximize effectiveness while minimizing risks.
Question: What is the KEGG identifier for this medication?
Answer: The KEGG ID is D04430. KEGG (Kyoto Encyclopedia of Genes and Genomes) is a resource for understanding high-level functions of biological systems, and having a KEGG ID supports further research on the medication.
Question: What is the license status of this product?
Answer: The product is licensed by the US FDA (United States Food and Drug Administration). FDA approval confirms the safety, efficacy, and quality of the medication.
Question: What is the elimination half-life of this product?
Answer: The elimination half-life is between 26.9 and 43.9 hours. The elimination half-life indicates how long the drug stays active in your body, which helps guide dosing schedules for optimal results.
Question: What is the formula of this medication?
Answer: The formula is C975H1513N267O304S26. This chemical composition ensures the product is a recombinant form of follicle-stimulating hormone, which is essential for its efficacy in treating infertility.
View all Follistim AQ Questions & Answers
